To our Valued Title21 Clients,
I’m thrilled to introduce myself as the new CEO of Title21 Health Solutions. It’s an honor to join a company with a strong reputation for providing innovative and reliable solutions to the biotherapy industry.
You may be wondering what this change in leadership means for you. First and foremost, I want to assure you that our commitment to your success remains unwavering. We are deeply invested in the stability and reliability of our products, and you can continue to count on us for exceptional customer service, ongoing support and continued investment in our software solutions.
My background in blood processing, therapies, and regulated software has given me a unique perspective on the challenges you face. In every company I have been associated with, FDA compliance has been a cornerstone to delivery of quality products, and I am committed to leveraging this experience to ensure that Title21 continues to deliver solutions that meet your evolving needs. We will continue to enhance our current offerings and explore new technologies that can improve patient care and streamline your operations.
I believe that our success is directly linked to your success. We value your partnership and are dedicated to working closely with you to ensure that our products and services continue to exceed your expectations.
I’m excited about this new chapter for Title21 and look forward to a continued strong partnership with you.
Sincerely,
Tony Pare
CEO
Title21 Health Solutions
